Dendrix

De novo Driver Exclusivity

Software for De novo discovery of mutated driver pathways

If you use Dendrix in your research, please cite:

F. Vandin, E. Upfal, and B.J. Raphael. (2011) De novo Discovery of Mutated Driver Pathways in Cancer. Genome Research, in press. Preprint
-or-